Vital-Signs 发表于 2025-3-25 07:24:13

Submitted on: 20 May 2005.
Revised on: 03 June 2005.
Accepted on: 27 June 2005.
NEUROPHARMACOLOGY---PERGAMON-ELSEVIER SCIENCE LTD

NIB 发表于 2025-3-25 08:22:21

Submitted on: 31 March 2020.
Revised on: 21 April 2020.
Accepted on: 07 May 2020.
NEUROPHARMACOLOGY---PERGAMON-ELSEVIER SCIENCE LTD

商品 发表于 2025-3-25 15:25:21

Submitted on: 18 March 2000.
Revised on: 26 April 2000.
Accepted on: 19 May 2000.
NEUROPHARMACOLOGY

协定 发表于 2025-3-25 16:39:45

Submitted on: 14 May 2020.
Revised on: 16 June 2020.
Accepted on: 10 July 2020.
NEUROPHARMACOLOGY---PERGAMON-ELSEVIER SCIENCE LTD

领巾 发表于 2025-3-26 00:03:31

Submitted on: 26 June 2022.
Revised on: 12 July 2022.
Accepted on: 08 August 2022.
NEUROPHARMACOLOGY

正面 发表于 2025-3-26 02:22:19

Submitted on: 22 November 2009.
Revised on: 15 December 2009.
Accepted on: 01 January 2010.
NEUROPHARMACOLOGY

失误 发表于 2025-3-26 05:20:56

http://reply.papertrans.cn/3/230/22980/22980-27.png

可行 发表于 2025-3-26 09:52:19

Submitted on: 19 February 2011.
Revised on: 18 March 2011.
Accepted on: 11 April 2011.
NEUROPHARMACOLOGY

NADIR 发表于 2025-3-26 16:42:01

http://reply.papertrans.cn/3/230/22980/22980-29.png

CLAMP 发表于 2025-3-26 18:30:21

http://reply.papertrans.cn/3/230/22980/22980-30.png
页: 1 2 [3] 4
查看完整版本: SCIE期刊NEUROPHARMACOLOGY 2024/2025影响因子:4.678 (NEUROPHARMACOLOGY) (0028-3908). (NEUROSCIENCES)(神经科学)Science Citation Inde